Ian George Charles

Title: Ian George Charles: Innovator in Vaccine Development

Introduction

Ian George Charles is a notable inventor based in Beckenham, GB. He has made significant contributions to the field of immunology, particularly in vaccine development. With a total of 7 patents to his name, his work has had a considerable impact on public health.

Latest Patents

Among his latest patents is a groundbreaking invention titled "Vaccines containing bacteria attenuated by mutation of the htrA gene." This patent focuses on an attenuated microorganism used in immunoprophylaxis, which is modified through a mutation in its DNA sequence. This microorganism can express DNA encoding a heterologous antigen, enhancing its effectiveness as a vaccine. Another significant patent is for "Polypeptides and vaccines for Bordetella pertussis and method of use." This invention involves a polypeptide designed for use in vaccines against Bordetella pertussis, B. parapertussis, or B. bronchiseptica. The polypeptide contains specific epitopes that are crucial for eliciting an immune response.

Career Highlights

Ian has worked with prominent companies in the pharmaceutical industry, including Glaxo Wellcome Inc. and Burroughs Wellcome Co. His experience in these organizations has allowed him to develop innovative solutions in vaccine technology.

Collaborations

Throughout his career, Ian has collaborated with esteemed colleagues such as Steven Neville Chatfield and Neil F Fairweather. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Ian George Charles is a distinguished inventor whose work in vaccine development has made a lasting impact on the field of immunology. His innovative patents and collaborations highlight his commitment to improving public health through scientific advancements.